Personalized Prehabilitation Improves Tolerance to Chemotherapy in Patients with Oesophageal Cancer.

Grigorios ChristodoulidisLaura J HallidayAthina A SamaraNeel BhuvaWon-Ho Edward ParkKrishna Moorthy

Published in: Current oncology (Toronto, Ont.) (2023)

The findings of this exploratory study suggest that prehabilitation is associated with better tolerance for chemotherapy. Further research is needed to establish the long-term impact of prehabilitation on oncological outcomes.

Keyphrases

locally advanced
papillary thyroid
rectal cancer
prostate cancer
type diabetes
adipose tissue
chemotherapy induced
childhood cancer
glycemic control